Deals, M&A

Grifols nabs Talecris in $3.4bn buyout deal

Posted on 07 June 2010

Spain's Grifols has struck a $3.4 billion deal to buy Talecris Biotherapeutics, finally delivering a premium return for the investment groups that backed the Research Triangle Park, NC-based biotech. Read the Grifols / Talecris story at Reuters

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
a1banner300x150animgif